BamSEC and AlphaSense Join Forces
Learn More

HilleVax Inc.

NASDAQ: HLVX    
Share price (12/24/24): $1.87    
Market cap (12/24/24): $93.1 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.11
from 10-K 16 pages January 16, 2024 Sean McLoughlin Re: Employment Offer Letter Dear Sean: Hillevax, Inc. (The “Company”) Is Pleased to Offer You a Position on the Terms Set Forth in This Letter (This “Agreement”), Effective as of January 16, 2024
12/34/56
EX-10.7
from 10-K 15 pages February 19, 2024 Aditya Kohli, PH.D. Re: Third Amended and Restated Employment Offer Letter Dear Dr. Kohli
12/34/56
EX-10.3
from 10-Q 4 pages Hillevax, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10
from 10-K 8 pages Amended and Restated Employment Agreement Between
12/34/56
EX-10
from 10-K 15 pages January 6, 2023 Shane Maltbie Re: Amended and Restated Employment Offer Letter Dear Shane
12/34/56
EX-10
from 10-K 17 pages January 6, 2023 David Socks Re: Second Amended and Restated Employment Offer Letter Dear Mr. Socks
12/34/56
EX-10
from 10-K 15 pages January 6, 2023 Aditya Kohli, PH.D. Re: Second Amended and Restated Employment Offer Letter Dear Dr. Kohli
12/34/56
EX-10
from 10-K 15 pages January 6, 2023 Robert Hershberg Re: Amended and Restated Employment Offer Letter Dear Mr. Hershberg
12/34/56
EX-10.4
from S-1/A 3 pages HilleVax, Inc. Non-Employee Director Compensation Program
12/34/56
EX-10.3
from S-1/A 18 pages HilleVax, Inc. 2022 Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 48 pages HilleVax, Inc. 2022 Incentive Award Plan
12/34/56
EX-10.11
from S-1 26 pages Dated December 17, 2021 Takeda Vaccines, Inc. and HilleVax, Inc. Transitional Services Agreement
12/34/56
EX-10.10
from S-1 67 pages License Agreement by and Between Takeda Vaccines, Inc. and HilleVax, Inc. License Agreement
12/34/56
EX-10.9
from S-1 17 pages Indemnification Agreement
12/34/56
EX-10.8
from S-1 9 pages Employment Agreement Between
12/34/56
EX-10.7
from S-1 11 pages May 12, 2021 David Socks Re: Amended and Restated Employment Offer Letter Dear Mr. Socks
12/34/56
EX-10.6
from S-1 11 pages May 12, 2021 Aditya Kohli, PH.D. Re: Amended and Restated Employment Offer Letter Dear Dr. Kohli
12/34/56
EX-10.5
from S-1 11 pages February 8, 2021 Robert Hershberg Re: Employment Offer Letter Dear Mr. Hershberg: HilleVax, Inc. (The “Company”) Is Pleased to Offer You a Position on the Terms Set Forth in This Letter (This “Agreement”), Effective as of February 8, 2021
12/34/56
EX-10.1
from S-1 46 pages HilleVax, Inc. 2021 Equity Incentive Plan
12/34/56
EX-10.11
from DRS/A 26 pages Dated December 17, 2021 Takeda Vaccines, Inc. and HilleVax, Inc. Transitional Services Agreement
12/34/56